Adapalene gel 0.1% vs ketoconazole cream 2% and their combination in treatment of pityriasis versicolor: A randomized clinical study

Pityriasis versicolor (PV) is a chronic superficial fungal infection. Management using azole drugs leads to drug resistance. The present study aimed to compare the clinical outcome of 0.1% adapalene gel vs 2% ketoconazole cream and their combination in PV. This randomized double‐blinded study was co...

Full description

Saved in:
Bibliographic Details
Published in:Dermatologic therapy 2020-05, Vol.33 (3), p.e13319-n/a
Main Authors: Bakr, Essam, Abdo, Hamed, Abd‐Elaziz, Hassan, Abd‐Elrazek, Hazem, Amer, Mohamed
Format: Article
Language:English
Subjects:
Acne Vulgaris - drug therapy
Adapalene
Dermatologic Agents - adverse effects
Gels
Humans
ketoconazole
Ketoconazole - adverse effects
Ointments
pityriasis versicolor
Tinea Versicolor - diagnosis
Tinea Versicolor - drug therapy
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3609-995f7c6d8090c9a29c4f369fac91490af24f9a8705d0ac1ed2df068888c097c93
cites cdi_FETCH-LOGICAL-c3609-995f7c6d8090c9a29c4f369fac91490af24f9a8705d0ac1ed2df068888c097c93
container_end_page n/a
container_issue 3
container_start_page e13319
container_title Dermatologic therapy
container_volume 33
creator Bakr, Essam
Abdo, Hamed
Abd‐Elaziz, Hassan
Abd‐Elrazek, Hazem
Amer, Mohamed
description Pityriasis versicolor (PV) is a chronic superficial fungal infection. Management using azole drugs leads to drug resistance. The present study aimed to compare the clinical outcome of 0.1% adapalene gel vs 2% ketoconazole cream and their combination in PV. This randomized double‐blinded study was conducted on 90 PV patients divided into three equal groups. GI was treated with topical ketoconazole 2% cream twice daily and placebo, GII was treated with topical 0.1% adapalene gel twice daily and placebo and GIII was treated with topical combination of 0.1% adapalene gel (at night) and ketoconazole 2% cream (in the morning). All patients received medications for 4 weeks. Evaluation was done at 2 and 4 weeks and included clinical assessment, laboratory assessment, and patient satisfaction. We found that after 4 weeks of treatment, all groups showed significant improvement. There was better response in GIII in terms of lower rate of positive potassium hydroxide staining, higher rate of significantly improved cases and higher rate of well‐satisfied patients. However, the difference fell short of statistical significance. We concluded that a combination of adapalene gel and ketoconazole cream is very effective in treatment of PV with no or mild side effects.
doi_str_mv 10.1111/dth.13319
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2378879607</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2378879607</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3609-995f7c6d8090c9a29c4f369fac91490af24f9a8705d0ac1ed2df068888c097c93</originalsourceid><addsrcrecordid>eNp1kD1vFDEQQC0URD6g4A-gaSJBsYk_7nZ30p0CIUiRaEK9cuwxceK1D9uX6FLzwzFcoGOameLNKx5jbwU_EW1Obb09EUoJfMEOxFJiN3KBe-1W2HdcYr_PDku541xIVOIV21dSjFKNwwH7ubJ6rQNFgu8UoAmP4aHAPdVkUtRPKRCYTHoGeQw6Wqi35DOYNN_4qKtPEXyE2og6U6yQHKx93Waviy_wQLl4k0LKZ7CC3P7T7J_Iggk-eqMDlLqx29fspdOh0JvnfcS-XXy6Pr_srr5-_nK-uuqM6jl2iEs3mN6OHLlBLdEsnOrRaYNigVw7uXCox4EvLddGkJXW8X5sYzgOBtURe7_zrnP6saFSp9kXQyHoSGlTJqmGcRyw50NDP-xQk1Mpmdy0zn7WeTsJPv2OPrXo05_ojX33rN3czGT_kX8rN-B0Bzz6QNv_m6aP15c75S8PY4w7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2378879607</pqid></control><display><type>article</type><title>Adapalene gel 0.1% vs ketoconazole cream 2% and their combination in treatment of pityriasis versicolor: A randomized clinical study</title><source>Wiley</source><creator>Bakr, Essam ; Abdo, Hamed ; Abd‐Elaziz, Hassan ; Abd‐Elrazek, Hazem ; Amer, Mohamed</creator><creatorcontrib>Bakr, Essam ; Abdo, Hamed ; Abd‐Elaziz, Hassan ; Abd‐Elrazek, Hazem ; Amer, Mohamed</creatorcontrib><description>Pityriasis versicolor (PV) is a chronic superficial fungal infection. Management using azole drugs leads to drug resistance. The present study aimed to compare the clinical outcome of 0.1% adapalene gel vs 2% ketoconazole cream and their combination in PV. This randomized double‐blinded study was conducted on 90 PV patients divided into three equal groups. GI was treated with topical ketoconazole 2% cream twice daily and placebo, GII was treated with topical 0.1% adapalene gel twice daily and placebo and GIII was treated with topical combination of 0.1% adapalene gel (at night) and ketoconazole 2% cream (in the morning). All patients received medications for 4 weeks. Evaluation was done at 2 and 4 weeks and included clinical assessment, laboratory assessment, and patient satisfaction. We found that after 4 weeks of treatment, all groups showed significant improvement. There was better response in GIII in terms of lower rate of positive potassium hydroxide staining, higher rate of significantly improved cases and higher rate of well‐satisfied patients. However, the difference fell short of statistical significance. We concluded that a combination of adapalene gel and ketoconazole cream is very effective in treatment of PV with no or mild side effects.</description><identifier>ISSN: 1396-0296</identifier><identifier>EISSN: 1529-8019</identifier><identifier>DOI: 10.1111/dth.13319</identifier><identifier>PMID: 32182387</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Acne Vulgaris - drug therapy ; Adapalene ; Dermatologic Agents - adverse effects ; Gels ; Humans ; ketoconazole ; Ketoconazole - adverse effects ; Ointments ; pityriasis versicolor ; Tinea Versicolor - diagnosis ; Tinea Versicolor - drug therapy ; Treatment Outcome</subject><ispartof>Dermatologic therapy, 2020-05, Vol.33 (3), p.e13319-n/a</ispartof><rights>2020 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3609-995f7c6d8090c9a29c4f369fac91490af24f9a8705d0ac1ed2df068888c097c93</citedby><cites>FETCH-LOGICAL-c3609-995f7c6d8090c9a29c4f369fac91490af24f9a8705d0ac1ed2df068888c097c93</cites><orcidid>0000-0002-4126-7962</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdth.13319$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdth.13319$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,786,790,27957,27958,50923,51032</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32182387$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bakr, Essam</creatorcontrib><creatorcontrib>Abdo, Hamed</creatorcontrib><creatorcontrib>Abd‐Elaziz, Hassan</creatorcontrib><creatorcontrib>Abd‐Elrazek, Hazem</creatorcontrib><creatorcontrib>Amer, Mohamed</creatorcontrib><title>Adapalene gel 0.1% vs ketoconazole cream 2% and their combination in treatment of pityriasis versicolor: A randomized clinical study</title><title>Dermatologic therapy</title><addtitle>Dermatol Ther</addtitle><description>Pityriasis versicolor (PV) is a chronic superficial fungal infection. Management using azole drugs leads to drug resistance. The present study aimed to compare the clinical outcome of 0.1% adapalene gel vs 2% ketoconazole cream and their combination in PV. This randomized double‐blinded study was conducted on 90 PV patients divided into three equal groups. GI was treated with topical ketoconazole 2% cream twice daily and placebo, GII was treated with topical 0.1% adapalene gel twice daily and placebo and GIII was treated with topical combination of 0.1% adapalene gel (at night) and ketoconazole 2% cream (in the morning). All patients received medications for 4 weeks. Evaluation was done at 2 and 4 weeks and included clinical assessment, laboratory assessment, and patient satisfaction. We found that after 4 weeks of treatment, all groups showed significant improvement. There was better response in GIII in terms of lower rate of positive potassium hydroxide staining, higher rate of significantly improved cases and higher rate of well‐satisfied patients. However, the difference fell short of statistical significance. We concluded that a combination of adapalene gel and ketoconazole cream is very effective in treatment of PV with no or mild side effects.</description><subject>Acne Vulgaris - drug therapy</subject><subject>Adapalene</subject><subject>Dermatologic Agents - adverse effects</subject><subject>Gels</subject><subject>Humans</subject><subject>ketoconazole</subject><subject>Ketoconazole - adverse effects</subject><subject>Ointments</subject><subject>pityriasis versicolor</subject><subject>Tinea Versicolor - diagnosis</subject><subject>Tinea Versicolor - drug therapy</subject><subject>Treatment Outcome</subject><issn>1396-0296</issn><issn>1529-8019</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1kD1vFDEQQC0URD6g4A-gaSJBsYk_7nZ30p0CIUiRaEK9cuwxceK1D9uX6FLzwzFcoGOameLNKx5jbwU_EW1Obb09EUoJfMEOxFJiN3KBe-1W2HdcYr_PDku541xIVOIV21dSjFKNwwH7ubJ6rQNFgu8UoAmP4aHAPdVkUtRPKRCYTHoGeQw6Wqi35DOYNN_4qKtPEXyE2og6U6yQHKx93Waviy_wQLl4k0LKZ7CC3P7T7J_Iggk-eqMDlLqx29fspdOh0JvnfcS-XXy6Pr_srr5-_nK-uuqM6jl2iEs3mN6OHLlBLdEsnOrRaYNigVw7uXCox4EvLddGkJXW8X5sYzgOBtURe7_zrnP6saFSp9kXQyHoSGlTJqmGcRyw50NDP-xQk1Mpmdy0zn7WeTsJPv2OPrXo05_ojX33rN3czGT_kX8rN-B0Bzz6QNv_m6aP15c75S8PY4w7</recordid><startdate>202005</startdate><enddate>202005</enddate><creator>Bakr, Essam</creator><creator>Abdo, Hamed</creator><creator>Abd‐Elaziz, Hassan</creator><creator>Abd‐Elrazek, Hazem</creator><creator>Amer, Mohamed</creator><general>John Wiley &amp; Sons, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4126-7962</orcidid></search><sort><creationdate>202005</creationdate><title>Adapalene gel 0.1% vs ketoconazole cream 2% and their combination in treatment of pityriasis versicolor: A randomized clinical study</title><author>Bakr, Essam ; Abdo, Hamed ; Abd‐Elaziz, Hassan ; Abd‐Elrazek, Hazem ; Amer, Mohamed</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3609-995f7c6d8090c9a29c4f369fac91490af24f9a8705d0ac1ed2df068888c097c93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Acne Vulgaris - drug therapy</topic><topic>Adapalene</topic><topic>Dermatologic Agents - adverse effects</topic><topic>Gels</topic><topic>Humans</topic><topic>ketoconazole</topic><topic>Ketoconazole - adverse effects</topic><topic>Ointments</topic><topic>pityriasis versicolor</topic><topic>Tinea Versicolor - diagnosis</topic><topic>Tinea Versicolor - drug therapy</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bakr, Essam</creatorcontrib><creatorcontrib>Abdo, Hamed</creatorcontrib><creatorcontrib>Abd‐Elaziz, Hassan</creatorcontrib><creatorcontrib>Abd‐Elrazek, Hazem</creatorcontrib><creatorcontrib>Amer, Mohamed</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Dermatologic therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bakr, Essam</au><au>Abdo, Hamed</au><au>Abd‐Elaziz, Hassan</au><au>Abd‐Elrazek, Hazem</au><au>Amer, Mohamed</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adapalene gel 0.1% vs ketoconazole cream 2% and their combination in treatment of pityriasis versicolor: A randomized clinical study</atitle><jtitle>Dermatologic therapy</jtitle><addtitle>Dermatol Ther</addtitle><date>2020-05</date><risdate>2020</risdate><volume>33</volume><issue>3</issue><spage>e13319</spage><epage>n/a</epage><pages>e13319-n/a</pages><issn>1396-0296</issn><eissn>1529-8019</eissn><notes>ObjectType-Article-2</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-News-1</notes><notes>ObjectType-Feature-3</notes><notes>content type line 23</notes><abstract>Pityriasis versicolor (PV) is a chronic superficial fungal infection. Management using azole drugs leads to drug resistance. The present study aimed to compare the clinical outcome of 0.1% adapalene gel vs 2% ketoconazole cream and their combination in PV. This randomized double‐blinded study was conducted on 90 PV patients divided into three equal groups. GI was treated with topical ketoconazole 2% cream twice daily and placebo, GII was treated with topical 0.1% adapalene gel twice daily and placebo and GIII was treated with topical combination of 0.1% adapalene gel (at night) and ketoconazole 2% cream (in the morning). All patients received medications for 4 weeks. Evaluation was done at 2 and 4 weeks and included clinical assessment, laboratory assessment, and patient satisfaction. We found that after 4 weeks of treatment, all groups showed significant improvement. There was better response in GIII in terms of lower rate of positive potassium hydroxide staining, higher rate of significantly improved cases and higher rate of well‐satisfied patients. However, the difference fell short of statistical significance. We concluded that a combination of adapalene gel and ketoconazole cream is very effective in treatment of PV with no or mild side effects.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>32182387</pmid><doi>10.1111/dth.13319</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-4126-7962</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1396-0296
ispartof Dermatologic therapy, 2020-05, Vol.33 (3), p.e13319-n/a
issn 1396-0296
1529-8019
language eng
recordid cdi_proquest_miscellaneous_2378879607
source Wiley
subjects Acne Vulgaris - drug therapy
Adapalene
Dermatologic Agents - adverse effects
Gels
Humans
ketoconazole
Ketoconazole - adverse effects
Ointments
pityriasis versicolor
Tinea Versicolor - diagnosis
Tinea Versicolor - drug therapy
Treatment Outcome
title Adapalene gel 0.1% vs ketoconazole cream 2% and their combination in treatment of pityriasis versicolor: A randomized clinical study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T18%3A33%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adapalene%20gel%200.1%25%20vs%20ketoconazole%20cream%202%25%20and%20their%20combination%20in%20treatment%20of%20pityriasis%20versicolor:%20A%20randomized%20clinical%20study&rft.jtitle=Dermatologic%20therapy&rft.au=Bakr,%20Essam&rft.date=2020-05&rft.volume=33&rft.issue=3&rft.spage=e13319&rft.epage=n/a&rft.pages=e13319-n/a&rft.issn=1396-0296&rft.eissn=1529-8019&rft_id=info:doi/10.1111/dth.13319&rft_dat=%3Cproquest_cross%3E2378879607%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3609-995f7c6d8090c9a29c4f369fac91490af24f9a8705d0ac1ed2df068888c097c93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2378879607&rft_id=info:pmid/32182387&rfr_iscdi=true